Search hospitals > Michigan > Grand Rapids
Mercy Health Saint Mary's
Claim this profileGrand Rapids, Michigan 49503
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Recurrence
306 reported clinical trials
3 medical researchers
Summary
Mercy Health Saint Mary's is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Recurrence and other specialties. Mercy Health Saint Mary's is involved with conducting 306 clinical trials across 484 conditions. There are 3 research doctors associated with this hospital, such as Kathleen J. Yost, Muhammad Farooq, and Jason Bennett.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Kathleen J. YostBronson Methodist Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
222 reported clinical trials
337 drugs studied
Muhammad FarooqMercy Health Saint Mary's4 years of reported clinical research
Studies Stroke
Studies Atrial Fibrillation
4 reported clinical trials
8 drugs studied
Jason BennettMercy Health Saint Mary's2 years of reported clinical research
Studies Overactive Bladder
1 reported clinical trial
1 drug studied
Clinical Trials running at Mercy Health Saint Mary's
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Melanoma
Lung Cancer
Cutaneous Melanoma
Pancreatic Cancer
Multiple Myeloma
Skin Cancer
Tumors
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Health Saint Mary's?
Mercy Health Saint Mary's is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Recurrence and other specialties. Mercy Health Saint Mary's is involved with conducting 306 clinical trials across 484 conditions. There are 3 research doctors associated with this hospital, such as Kathleen J. Yost, Muhammad Farooq, and Jason Bennett.